Worlds apart? A comparison of the new product development strategies of biopharmaceutical firms in Europe and the USA. Industry and Innovation.

Globally the biopharmaceutical industry is characterized by strong competition, research-intensive and protracted new product development (NPD) processes, intensive regulation and extensive alliance activity. Policy regimes and operating environments differ markedly, however. Here we examine how the...

Full description

Saved in:
Bibliographic Details
Main Authors: Tianjiao Xia, Stephen Roper
Format: Default Article
Published: 2009
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!